The following table presents the changes in goodwill during the six months ended June 30, 2024 (in thousands):


	Total Company
Balance as of December 31, 2023	$	166,270
Foreign currency translation	(220)
Balance as of June 30, 2024	$	166,050

The Company reviews goodwill for impairment annually on October 31, or more frequently if events or circumstances indicate that an impairment loss may have occurred. The Company operates as one segment, which is the sole reporting unit of the Company, and therefore goodwill is tested for impairment at the consolidated level. Accordingly, when assessing whether an impairment test is required more frequently than on its annual testing date, the Company considers whether events or circumstances have taken place that indicate it is more likely than not that the Company’s enterprise fair value is less than the carrying amount of its one reporting unit, including goodwill. Due to the impairment of the Immersive Healthcare asset group during the three and six months ended June 30, 2024, the Company assessed the reporting unit for impairment and determined there was no impairment of goodwill.